CompletedPHASE1, PHASE2NCT01709071

Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pauline Verdijk
Principal Investigator
Pauline Verdijk, PhD
National Institute for Public Health and the Environment (RIVM)
Intervention
IPV(drug)
Enrollment
140 target
Eligibility
All sexes
Timeline
20122013

Study locations (7)

Collaborators

World Health Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01709071 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials